We believe that one of the mechanisms underlying the attenuation of arthritis development by SA13353 is inhibition of TNF-a production by inflammatory cells exposed to neuropeptides released from TRPV1-expressing afferent C fibers. This evidence concerns the gene TRPV1 and arthritic joint disease.